Quote For Genzyme Corporation GENZ.O

Genzyme Corporation (GENZ.O) (Nasdaq)
sector: Healthcare · industry: Biotechnology ·
As of  25 Nov 2009
51.52USD
Price Change
+1.14
Percent Change
+2.26%
 
Research a stock:   symbol lookup
$51.52
25 Nov 2009
+2.26%
$51.52
--
3,283,069
$0.00
$0.00
$73.75
$47.09
0.31
6,350,807

News

Press Releases

Key Developments

Officers

Name Current Position Compensation
Termeer, Henri Chairman of the Board, President, Chief Executive Officer 13,773,800
Wyzga, Michael Chief Financial Officer, Executive Vice President - Finance 3,019,200
Wirth, Peter Executive Vice President - Legal and Corporate Development, Secretary 3,246,360

Key Ratios and Statistics

Share Related Items
Market Cap (Mil.) $13,926.29
Shares Outstanding (Mil.) 270.31
Float (Mil.) 262.20
Dividend Information
Yield % -99,999.99
Annual Dividend ($ USD) 0.00
Payout Ratio(TTM) % 0.00
Financial Strength
Quick Ratio 2.26
Current Ratio 2.55
LT Debt/Equity 1.55
Total Debt/Equity 1.66
Valuation Ratios
Price/Earnings(TTM) 29.38
Price/Sales(TTM) 3.02
Price/Book(TTM) 1.80
Price/Cash Flow(TTM) 15.24
Per Share Data
Earnings(TTM) $1.80
Sales(TTM) $16.59
Book Value(MRQ) $28.70
Cash Flow(TTM) $3.29
Cash(MRQ) $3.20
Management Effectiveness
Return on Equity(TTM) 6.54
Return on Assets(TTM) 5.01
Return on Investment(TTM) 5.78
Margins
Gross Margin(TTM) % 71.65
Operating Margin(TTM) % 13.98
Profit Margin(TTM) % 10.54

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
advertisement